SCHEMBL7215982

SCHEMBL7215982

CCCc1ccc(Oc2ccc3c(c2)C=C(C(=O)OC)CCS3(=O)=O)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACACB O00763 2/20 0.36
ACACA Q13085 1/20 0.36
CA12 O43570 2/20 0.34
CA9 Q16790 2/20 0.34
CA2 P00918 1/20 0.34
MAPT P10636 3/20 0.34
TP53 P04637 1/20 0.34
CTSL P07711 1/20 0.34
ALDH1A1 P00352 2/20 0.33
P2RY14 Q15391 1/20 0.33
THRB P10828 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
MDH1 P40925 2/20 0.33
NPC1 O15118 1/20 0.33
CASP3 P42574 1/20 0.33
RAB9A P51151 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
SENP8 Q96LD8 1/20 0.33
SENP7 Q9BQF6 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7222347 0.89 ACACB (0.35) ACACBACACAALDH1A1P2RY14THRB
SCHEMBL7216356 0.88 KDM4E (0.34) CA12CA9CA2CTSLALDH1A1
SCHEMBL7216635 0.88 LTA4H (0.39) ACACBACACACA12CA9CA2
SCHEMBL7971878 0.87 MCL1 (0.38) ACACBACACACA12CA9MAPT
SCHEMBL7216131 0.84 MAPT (0.36) ACACBACACACA12CA9CA2
SCHEMBL7221547 0.84 LMNA (0.40) ACACBMAPTALDH1A1MEN1KMT2A
SCHEMBL7216104 0.82 CA12 (0.49) CA12CA9CA2MAPTTP53
SCHEMBL7218066 0.80 NPC1 (0.41) MAPTTP53ALDH1A1MEN1KMT2A
SCHEMBL7218242 0.80 NPC1 (0.37) CA12CA9CA2MAPTTP53
SCHEMBL7218022 0.80 ACACB (0.38) ACACBACACAMAPTALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6627651-B1 Exhibiting preventive and therapeutic effects against HIV infectious diseases wherein R1 is an optionally substituted five- or six-membered ring group; X1 is a free valency or the like; W is a divalent group and inhibitors of HIV (human TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2003-09-30 US disclosed
EP-1182195-A1 CYCLIC COMPOUNDS AND USES THEREOF Takeda Chemical Industries, Ltd. (JP) 2002-02-27 EP disclosed